Insight Molecular Diagnostics Inc. (IMDX)
Nasdaq: IMDX · In Vitro & In Vivo Diagnostic Substances · Nashville, TN · filing with the SEC since 2015
Who owns Insight Molecular Diagnostics Inc.
As filed with the SECHolders of 5% or more
4
Broadwood Partners, L.P. holds 39.7% of Common Stock, no par value, as its SCHEDULE 13D/A filed Apr 27, 2026 says.
Directors and officers
6
report now, of 28 people on the record since 2015. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Broadwood Partners, L.P.
SCHEDULE 13D/A · filed Apr 27, 2026 · Common Stock, no par value · 37.4% in Feb 12, 2026
Patrick W. Smith
SCHEDULE 13G/A · filed Dec 27, 2024 · Common Stock, no par value
AWM Investment Company, Inc.
SCHEDULE 13G/A · filed May 9, 2025 · Common Stock · 7.5% in Feb 14, 2025
Bio-Rad Laboratories, Inc.Class A
SCHEDULE 13G/A · filed Mar 4, 2025 · Common Shares, No Par Value
What IMDX reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Awm
An entity · legal entity · owns, named in the 10-K filed Mar 26, 2026
Broadwood Capital LP
An entity · legal entity · owns, named in the 10-K filed Mar 26, 2026
Broadwood Partners LP
An entity · legal entity · owns, named in the 10-K filed Mar 26, 2026
Determa CNI
An entity · legal entity · owns, named in the 10-K filed Mar 26, 2026
Determa IO
An entity · legal entity · owns, named in the 10-K filed Mar 26, 2026
Pura Vida
An entity · legal entity · owns, named in the 10-K filed Mar 26, 2026
Pura Vida Investments LLC
An entity · legal entity · owns, named in the 10-K filed Mar 26, 2026
Chronix Merger
A company bought · acquisition · owns, named in the 10-K filed Mar 26, 2026
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 35 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Broadwood Capital Inc | 10% owner | 0 | $0 | 0 | 6 | $700,000 |
| Broadwood Partners, L.P. | 10% owner | 0 | $0 | 0 | 6 | $2.0M |
| Bradsher Neal C | 10% owner | 0 | $0 | 0 | 2 | $3.0M |